Substituted phenyl sulfonamides as selective .beta.3 agonists for the treatment of diabetes and obesity
CA 2114712 A1 · Owner: Ok, Hyun O. · Inventors: Ok, Hyun O.; Weber, Ann E.; Fisher, Michael H.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
TITLE OF THE INVENTION, SUBSTITUTED PHENYL SULFONAMIDES AS SELECTIVE .beta.3 AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY ABSTRACT OF THE INVENTION, Substituted phenylsulfonamides are selective .beta.3 adrenergic receptor agonists with very little .beta.1 and .beta.2 adrenergic receptor activity and as such the compounds are capable of increasing lipolysis and energy expenditure in cells. The compounds thus have potent activity in the treatment of Type II diabetes and obesity. The compounds can also be used to lower triglyceride levels and cholesterol levels or raise high density lipoprotein levels or to decrease gut motility. In addition the, compounds can be used to reduced …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 1, 1994. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 1, 2014.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 1, 2016.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.